
[ Wed, Jan 29th ]: blockonomi
[ Wed, Jan 29th ]: businessday
[ Wed, Jan 29th ]: NextBigFuture
[ Wed, Jan 29th ]: decrypt
[ Wed, Jan 29th ]: Yahoo
[ Wed, Jan 29th ]: Gigwise
[ Wed, Jan 29th ]: LBC
[ Wed, Jan 29th ]: MSN
[ Wed, Jan 29th ]: MSN
[ Wed, Jan 29th ]: MSN
[ Wed, Jan 29th ]: ABC

[ Tue, Jan 28th ]: Yahoo
[ Tue, Jan 28th ]: komonews
[ Tue, Jan 28th ]: CNET
[ Tue, Jan 28th ]: PopSugar
[ Tue, Jan 28th ]: NextBigFuture
[ Tue, Jan 28th ]: NextBigFuture
[ Tue, Jan 28th ]: Mint
[ Tue, Jan 28th ]: WESH
[ Tue, Jan 28th ]: Yahoo
[ Tue, Jan 28th ]: NDTV
[ Tue, Jan 28th ]: WREG
[ Tue, Jan 28th ]: SHINE
[ Tue, Jan 28th ]: Salon
[ Tue, Jan 28th ]: news10nbc
[ Tue, Jan 28th ]: Mint
[ Tue, Jan 28th ]: MyJoyOnline
[ Tue, Jan 28th ]: NextBigFuture
[ Tue, Jan 28th ]: MSN
[ Tue, Jan 28th ]: Forbes
[ Tue, Jan 28th ]: MSN
[ Tue, Jan 28th ]: MSN
[ Tue, Jan 28th ]: VentureBeat

[ Mon, Jan 27th ]: wwmt
[ Mon, Jan 27th ]: Forbes
[ Mon, Jan 27th ]: TechCrunch
[ Mon, Jan 27th ]: NextBigFuture
[ Mon, Jan 27th ]: NextBigFuture
[ Mon, Jan 27th ]: Time
[ Mon, Jan 27th ]: MSN
[ Mon, Jan 27th ]: MSN
[ Mon, Jan 27th ]: WTHR
[ Mon, Jan 27th ]: Forbes
[ Mon, Jan 27th ]: Vanguard
[ Mon, Jan 27th ]: CNET
[ Mon, Jan 27th ]: MSN
[ Mon, Jan 27th ]: Chronicle
[ Mon, Jan 27th ]: Forbes
India raising the bar on drug formulation challenges


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre.

Read the Full MSN Article at:
[ https://www.msn.com/en-in/science/biochemistry/india-raising-the-bar-on-drug-formulation-challenges/ar-AA1xZ927 ]
Similar Science and Technology Publications
[ Fri, Jan 24th ]: MSN
[ Tue, Jan 21st ]: STAT
[ Sun, Jan 19th ]: MSN
[ Fri, Jan 17th ]: Wired
[ Wed, Jan 15th ]: MSN
[ Thu, Jan 09th ]: MSN
[ Thu, Jan 09th ]: MSN
[ Sun, Jan 05th ]: MSN
[ Thu, Dec 05th 2024 ]: pharmaphorum
[ Mon, Dec 02nd 2024 ]: Tim Hastings
[ Mon, Dec 02nd 2024 ]: Tim Hastings